CLINICAL EXPERIENCE WITH THE MONOAMINE OXIDASE INHIBITOR, DL-SERINE-N-ISOPROPYLHYDRAZIDE (RO 4-1038), IN THE TREATMENT OF HYPERTENSION.
D000959:Antihypertensive Agents; D002740:Chlorothiazide; D004361:Drug Tolerance; D005853:Geriatrics; D006801:Humans; D006973:Hypertension; D006977:Hypertension, Renal; D007022:Hypotension; D007211:Indoles; D007490:Iproniazid; D007668:Kidney; D008996:Monoamine Oxidase Inhibitors; D012110:Reserpine; D012694:Serine / Q000031:analogs & derivatives; D014116:Toxicology
D000959:Antihypertensive Agents; D007211:Indoles; D008996:Monoamine Oxidase Inhibitors; C017713:serine isopropylhydrazide; D012694:Serine; D002740:Chlorothiazide; D012110:Reserpine; D007490:Iproniazid
ANTIHYPERTENSIVE AGENTS; CHLOROTHIAZIDE; DRUG TOLERANCE; GERIATRICS; HYPERTENSION; HYPERTENSION, RENAL; HYPOTENSION; INDOLES; IPRONIAZID; MONOAMINE OXIDASE INHIBITORS; RESERPINE; TOXICOLOGIC REPORT